277 related articles for article (PubMed ID: 24976114)
1. Main ion channels and receptors associated with visceral hypersensitivity in irritable bowel syndrome.
de Carvalho Rocha HA; Dantas BP; Rolim TL; Costa BA; de Medeiros AC
Ann Gastroenterol; 2014; 27(3):200-206. PubMed ID: 24976114
[TBL] [Abstract][Full Text] [Related]
2. Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome.
Fuentes IM; Christianson JA
Neurogastroenterol Motil; 2016 Nov; 28(11):1613-1618. PubMed ID: 27781369
[TBL] [Abstract][Full Text] [Related]
3. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome.
Keszthelyi D; Troost FJ; Masclee AA
Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(2):G141-54. PubMed ID: 22595988
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A
Asano T; Takenaga M
J Clin Med; 2017 Nov; 6(11):. PubMed ID: 29099770
[TBL] [Abstract][Full Text] [Related]
5. Colonic overexpression of the T-type calcium channel Ca
Scanzi J; Accarie A; Muller E; Pereira B; Aissouni Y; Goutte M; Joubert-Zakeyh J; Picard E; Boudieu L; Mallet C; Gelot A; Ardid D; Carvalho FA; Dapoigny M
Neurogastroenterol Motil; 2016 Nov; 28(11):1632-1640. PubMed ID: 27196538
[TBL] [Abstract][Full Text] [Related]
6. Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.
Cenac N; Bautzova T; Le Faouder P; Veldhuis NA; Poole DP; Rolland C; Bertrand J; Liedtke W; Dubourdeau M; Bertrand-Michel J; Zecchi L; Stanghellini V; Bunnett NW; Barbara G; Vergnolle N
Gastroenterology; 2015 Aug; 149(2):433-44.e7. PubMed ID: 25911511
[TBL] [Abstract][Full Text] [Related]
7. Revisiting concepts of visceral nociception in irritable bowel syndrome.
Keszthelyi D; Troost FJ; Simrén M; Ludidi S; Kruimel JW; Conchillo JM; Masclee AA
Eur J Pain; 2012 Nov; 16(10):1444-54. PubMed ID: 22504901
[TBL] [Abstract][Full Text] [Related]
8. Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome.
Beckers AB; Weerts ZZRM; Helyes Z; Masclee AAM; Keszthelyi D
Aliment Pharmacol Ther; 2017 Nov; 46(10):938-952. PubMed ID: 28884838
[TBL] [Abstract][Full Text] [Related]
9. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments.
Farzaei MH; Bahramsoltani R; Abdollahi M; Rahimi R
J Neurogastroenterol Motil; 2016 Oct; 22(4):558-574. PubMed ID: 27431236
[TBL] [Abstract][Full Text] [Related]
10. Blockade of BK channels attenuates chronic visceral hypersensitivity in an IBS-like rat model.
Fan F; Chen Y; Chen Z; Guan L; Ye Z; Tang Y; Chen A; Lin C
Mol Pain; 2021; 17():17448069211040364. PubMed ID: 34407673
[TBL] [Abstract][Full Text] [Related]
11. PPARγ: A turning point for irritable bowel syndrome treatment.
Roudsari NM; Lashgari NA; Zandi N; Pazoki B; Momtaz S; Sahebkar A; Abdolghaffari AH
Life Sci; 2020 Sep; 257():118103. PubMed ID: 32681913
[TBL] [Abstract][Full Text] [Related]
12. The traditional herbal medicines mixture, Banhasasim-tang, relieves the symptoms of irritable bowel syndrome via modulation of TRPA1, NaV1.5 and NaV1.7 channels.
Choi NR; Kwon MJ; Choi WG; Kim SC; Park JW; Nam JH; Kim BJ
J Ethnopharmacol; 2023 Aug; 312():116499. PubMed ID: 37059250
[TBL] [Abstract][Full Text] [Related]
13. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
[TBL] [Abstract][Full Text] [Related]
14. Role of antispasmodics in the treatment of irritable bowel syndrome.
Annaházi A; Róka R; Rosztóczy A; Wittmann T
World J Gastroenterol; 2014 May; 20(20):6031-43. PubMed ID: 24876726
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and neural mechanism of acupuncture therapy in the treatment of visceral hypersensitivity in irritable bowel syndrome.
Yang Y; Wang J; Zhang C; Guo Y; Zhao M; Zhang M; Li Z; Gao F; Luo Y; Wang Y; Cao J; Du M; Wang Y; Lin X; Xu Z
Front Neurosci; 2023; 17():1251470. PubMed ID: 37732301
[TBL] [Abstract][Full Text] [Related]
16. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.
Stasi C; Bellini M; Bassotti G; Blandizzi C; Milani S
Tech Coloproctol; 2014 Jul; 18(7):613-21. PubMed ID: 24425100
[TBL] [Abstract][Full Text] [Related]
17. Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M; Hongo M; Fukudo S
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
[TBL] [Abstract][Full Text] [Related]
18. Markers for visceral hypersensitivity in patients with irritable bowel syndrome.
Ludidi S; Mujagic Z; Jonkers D; Keszthelyi D; Hesselink M; Kruimel J; Conchillo J; Masclee A
Neurogastroenterol Motil; 2014 Aug; 26(8):1104-11. PubMed ID: 24920528
[TBL] [Abstract][Full Text] [Related]
19. Giardia duodenalis induces paracellular bacterial translocation and causes postinfectious visceral hypersensitivity.
Halliez MC; Motta JP; Feener TD; Guérin G; LeGoff L; François A; Colasse E; Favennec L; Gargala G; Lapointe TK; Altier C; Buret AG
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(8):G574-85. PubMed ID: 26744469
[TBL] [Abstract][Full Text] [Related]
20. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
Wouters MM; Balemans D; Van Wanrooy S; Dooley J; Cibert-Goton V; Alpizar YA; Valdez-Morales EE; Nasser Y; Van Veldhoven PP; Vanbrabant W; Van der Merwe S; Mols R; Ghesquière B; Cirillo C; Kortekaas I; Carmeliet P; Peetermans WE; Vermeire S; Rutgeerts P; Augustijns P; Hellings PW; Belmans A; Vanner S; Bulmer DC; Talavera K; Vanden Berghe P; Liston A; Boeckxstaens GE
Gastroenterology; 2016 Apr; 150(4):875-87.e9. PubMed ID: 26752109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
